Market Research Report
Tissue Engineered-Skin Substitutes (Wound Care Devices) - Global Market Analysis and Forecast Model
|Published by||GlobalData||Product code||540340|
Delivery time: 1-2 business days
|Tissue Engineered-Skin Substitutes (Wound Care Devices) - Global Market Analysis and Forecast Model|
|Published: October 31, 2018||Content info:||
Tissue Engineered-Skin Substitutes (Wound Care Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Wound Care Devices therapeutic area.
Epidermal Wounds which show delayed healing process can lead to risks to a patient's health, including death and serious chronic wound formation. Skin substitutes have led to promising recovery practices for refractory wounds by providing cells, soluble mediators, and extracellular matrix materials needed to stimulate healing. Skin substitutes can be derived from human tissue, non-human tissue, a composite, or synthetic materials. The tissue engineered-skin substitutes market is segmented into cellular skin substitutes based on amniotic membrane, other cellular skin substitutes, acellular skin substitutes based on amniotic membrane, and other acellular skin substitutes.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Derma Sciences, LifeCell Corporation, LifeNet Health, MiMedx, Organogenesis, Smith & Nephew, Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -